Endocrinology and Metabolism Clinics of North America

Papers
(The median citation count of Endocrinology and Metabolism Clinics of North America is 1. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
An Update on the Epidemiology of Type 2 Diabetes213
Postmenopausal Osteoporosis144
Lipid and Lipoprotein Metabolism66
Physiology of Calcium Homeostasis63
Diagnosis of Polycystic Ovary Syndrome51
Prevention of Microvascular Complications of Diabetes41
Assessment of Cardiovascular Disease Risk41
Screening for Diabetes and Prediabetes37
2022 Update on Clinical Management of Graves Disease and Thyroid Eye Disease34
Diabetes and Osteoporosis31
Pediatric Thyroid Cancer30
New and Emerging Technologies in Type 1 Diabetes29
Osteoporosis26
Anaplastic Thyroid Cancer25
Characterizing Multimorbidity from Type 2 Diabetes23
The Changing Nature of Mortality and Morbidity in Patients with Diabetes21
Cardiometabolic Risk in Polycystic Ovary Syndrome20
Inhaled Corticosteroids and Endocrine Effects in Childhood18
Testosterone Replacement Therapy in Hypogonadal Men18
Regulation of the Hypothalamic-Pituitary-Testicular Axis: Pathophysiology of Hypogonadism17
Definition and Classification of Diabetes and Prediabetes and Emerging Data on Phenotypes17
Safety of Statins and Nonstatins for Treatment of Dyslipidemia16
Ethnic Disparities in Diabetes16
Epidemiology of Male Hypogonadism16
Pediatric Type 2 Diabetes: Not a Mini Version of Adult Type 2 Diabetes15
Dyslipidemia in Diabetes15
Polycystic Ovary Syndrome14
Updates on Osteoporosis in Men14
Nonclassic Congenital Adrenal Hyperplasia14
Role of Bone Turnover Markers in Osteoporosis Therapy14
Hereditary Primary Hyperparathyroidism13
Hypertriglyceridemia13
Obesity and Aging13
Delayed and Precocious Puberty: Genetic Underpinnings and Treatments12
Diabetes and Osteoporosis12
Update on Rare Adverse Events from Osteoporosis Therapy and Bisphosphonate Drug Holidays12
Genetics of Polycystic Ovary Syndrome12
Postmenopausal Hyperandrogenism11
Testosterone, Diabetes Risk, and Diabetes Prevention in Men11
Vitamin D–dependent Hypercalcemia11
Denosumab Discontinuation in Patients Treated for Low Bone Density and Osteoporosis11
Nonalcoholic Fatty Liver Disease11
Evaluating the Impact of Acromegaly on Quality of Life10
Prevention of Type 2 Diabetes10
100 years of Insulin: Why is Insulin So Expensive and What Can be Done to Control Its Cost?10
Diabetes in Youth10
Management of Women with Polycystic Ovary Syndrome During Pregnancy10
Bone Health in Childhood Chronic Disease10
Phthalate Exposure, Adolescent Health, and the Need for Primary Prevention9
Glucocorticoid- and Transplantation-Induced Osteoporosis9
Testosterone Treatment As a Function-Promoting Therapy in Sarcopenia Associated with Aging and Chronic Disease9
Hypercalcemia of Malignancy9
Overview of Atypical Diabetes9
Accurate Measurement and Harmonized Reference Ranges for Total and Free Testosterone Levels9
Type 1 Diabetes and Aging8
Management of Menopause Symptoms and Quality of Life during the Menopause Transition8
Advances in the Bone Health Assessment of Children7
Pathophysiology of Hypercalcemia7
Metabolic-Associated Fatty Liver Disease and the Gut Microbiota7
Treatment of Hypercalcemia of Malignancy7
Age-Associated Abnormalities of Water Homeostasis7
Sexual Dysfunctions in Women7
The Inherited Hypercholesterolemias7
Symptoms of Late-Onset Hypogonadism in Men6
Thyroid and Aging6
Tertiary and Postrenal Transplantation Hyperparathyroidism6
Parathyroid Carcinoma and Ectopic Secretion of Parathyroid hormone6
Hypercalcemia in Pregnancy6
Male Reproduction and Aging6
The Future of Thyroid Nodule Risk Stratification6
Endocrine Sequelae in Childhood Cancer Survivors6
Pathobiology of Metabolic-Associated Fatty Liver Disease6
Root Cause for Metabolic Syndrome and Type 2 Diabetes6
Metabolic-Associated Fatty Liver Disease and Diabetes6
Testicular Dysfunction Among Cancer Survivors6
Drug-Related Hypercalcemia6
Disparities in Thyroid Care6
Fertility Issues in Polycystic Ovarian Disease5
Hyperandrogenic Anovulation5
Update on Approved Osteoporosis Therapies Including Combination and Sequential Use of Agents5
Use of Testosterone in Postmenopausal Women5
Assessment of Skeletal Strength5
Ameliorating Cardiovascular Risk in Patients with Type 2 Diabetes5
Metabolic-Associated Fatty Liver Disease and Sarcopenia5
Role of Levothyroxine/Liothyronine Combinations in Treating Hypothyroidism5
Rekindling Hope for Remission5
Quality of Life in Primary Hyperparathyroidism5
Hormonal Injustice5
Diagnostic and Treatment Considerations for Thyroid Cancer in Women of Reproductive Age and the Perinatal Period5
Disparities in Access to High-Volume Surgeons and Specialized Care5
Cardiovascular Implications of Metabolic Dysfunction-Associated Fatty Liver Disease5
Lipid Disorders and Metabolic-Associated Fatty Liver Disease5
Endocrinology of Taste with Aging4
Sporadic Primary Hyperparathyroidism4
Management of Metabolic-Associated Fatty Liver Disease4
Acute and Chronic Adverse Outcomes of Type 1 Diabetes4
Novel Therapeutics for Advanced Differentiated Thyroid Cancer4
Minimally Invasive Techniques for the Management of Thyroid Nodules4
The Interlink Between Metabolic-Associated Fatty Liver Disease and Polycystic Ovary Syndrome4
Emerging and Public Health Challenges Existing in Gestational Diabetes Mellitus and Diabetes in Pregnancy4
Fertility Considerations in Hypogonadal Men4
Diagnosis and Evaluation of Hypogonadism4
Novel Therapeutics and Treatment Strategies for Medullary Thyroid Cancer4
Evaluating Patient-Reported Outcomes in Cushing’s Syndrome4
Endocrine Disorders with Parathyroid Hormone-Independent Hypercalcemia4
Equity in Obesity Review3
Nontraditional Aspects of Sporadic Primary Hyperparathyroidism3
Remission in Ketosis-Prone Diabetes3
New and Emerging Therapies for Dyslipidemia3
Update on Approaches to Improve Delivery and Quality of Care for People with Diabetes3
LDL Cholesterol—How Low Can We Go?3
Remission with an Intervention3
Racial and Ethnic Disparities in Access to and Outcomes of Infertility Treatment and Assisted Reproductive Technology in the United States3
Physiology Reconfigured: How Does Bariatric Surgery Lead to Diabetes Remission?3
Lipoprotein Assessment in the twenty-first Century3
Patient-Reported Outcomes in Endoscopic Endonasal Skull Base Surgery3
Prevention of Diabetes Macrovascular Complications and Heart Failure3
Growth Hormone and Aging3
Thyroid Dysfunction from Treatments for Solid Organ Cancers3
Intervention with Therapeutic Agents, Understanding the Path to Remission in Type 2 Diabetes3
High-Density Lipoprotein and Cardiovascular Disease—Where do We Stand?3
Islet Cell Therapy and Stem Cell Therapy for Type 1 Diabetes3
Rare Causes of Hypercalcemia3
Preconception Counseling and Care for Pregnant Women with Thyroid Disease3
Management of Dyslipidemia in Endocrine Diseases3
Population-Level Approaches to Preventing Type 2 Diabetes Globally3
Big Fish or No Fish; Eicosapentaenoic Acid and Cardiovascular Disease3
Pregnancy and Metabolic-Associated Fatty Liver Disease2
Intervention with Therapeutic Agents, Understanding the Path to Remission to Type 2 Diabetes2
A Bidirectional Association Between Obstructive Sleep Apnea and Metabolic-Associated Fatty Liver Disease2
Metabolic-Associated Fatty Liver Disease: A Disastrous Human Health Challenge2
Quality of Life in Patients with Adrenal Insufficiency2
Advancing Equity in Diabetes Prevention, Treatment, and Outcomes2
Monitoring of Testosterone Replacement Therapy to Optimize the Benefit-to-Risk Ratio2
Metabolic-Associated Fatty Liver Disease in Childhood and Adolescence2
The Effects of Testosterone Treatment on Cardiovascular Health2
Newer Glucose-Lowering Therapies in Older Adults with Type 2 Diabetes2
Updates on Osteoporosis2
Diabetes Care in Humanitarian Settings2
Physiology of the Weight-Reduced State and Its Impact on Weight Regain2
Body Image Disorders and Anabolic Steroid Withdrawal Hypogonadism in Men2
Use of Patient-Reported Outcomes for Assessing Diabetes Outcomes2
Less-Intensive Management Options for Low-Risk Thyroid Cancer2
Anticipation of Precision Diabetes and Promise of Integrative Multi-Omics2
Lean Metabolic-Associated Fatty Liver Disease2
Interventions Across the Translational Research Spectrum2
What Is a Honeymoon in Type 1, Can It Go into Remission?2
Risks of Testosterone for Postmenopausal Women2
Emerging Technologies and Therapeutics for Type 1 Diabetes1
Sociodemographic Factors in Pituitary Adenomas1
Global Health Disparities in Childhood Rickets1
Incorporating the Six Core Elements of Health Care Transition in Type 1 Diabetes Care for Emerging Adults1
Testosterone Treatment and the Risk of Prostate Adverse Events1
Recognizing and Addressing Health Inequities in Endocrinology and Diabetes1
Normal Puberty1
Primary Amenorrhea and Premature Ovarian Insufficiency1
Thyroid Disorders: An Update1
Hypercalcemia1
Geriatric Syndromes in Older Adults with Diabetes1
Sex Hormones and Cardiovascular Disease in Relation to Menopause1
Peer Support to Enhance Type 2 Diabetes Prevention Among African American and Latino Adults1
Presentation and Care for Children with Peripheral Precocious Puberty1
Updates on Osteoporosis1
Insights into the Genetic Underpinnings of Endocrine Traits from Large-Scale Genome-Wide Association Studies1
Type 1 Diabetes and Cardiovascular Health1
2021 Updates on Osteoporosis Diagnosis and Therapy1
Diabetic Kidney Care Redefined with a New Way into Remission1
Racial and Ethnic Disparities in Metabolic Bone Disease1
Optimizing Glycemic Outcomes for Minoritized and Medically Underserved Adults Living with Type 1 Diabetes1
Advances in Pharmacotherapeutics, Metabolic Surgery, and Technology for Diabetes1
Optimized Use of the Electronic Health Record and Other Clinical Resources to Enhance the Management of Hypogonadal Men1
The Benefits and Risks of Testosterone Treatment in Older Hypogonadal Men1
Type 1 Diabetes1
Type 1 Diabetes Screening and Diagnosis1
Evaluation and Management of Lipids and Lipoproteins in Children and Adolescents1
0.033828020095825